A detailed history of Segall Bryant & Hamill, LLC transactions in Azenta, Inc. stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 288,100 shares of AZTA stock, worth $13.7 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
288,100
Holding current value
$13.7 Million
% of portfolio
0.2%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$40.37 - $51.57 $11.6 Million - $14.9 Million
288,100 New
288,100 $14.4 Million
Q2 2024

Aug 14, 2024

BUY
$50.27 - $59.04 $150,608 - $176,883
2,996 Added 2.83%
108,831 $5.73 Million
Q1 2024

May 15, 2024

SELL
$57.82 - $67.51 $87,655 - $102,345
-1,516 Reduced 1.41%
105,835 $6.38 Million
Q4 2023

Feb 14, 2024

BUY
$44.02 - $66.3 $15,407 - $23,205
350 Added 0.33%
107,351 $6.99 Million
Q3 2023

Nov 09, 2023

SELL
$44.08 - $57.76 $30,150 - $39,507
-684 Reduced 0.64%
107,001 $5.37 Million
Q2 2023

Aug 11, 2023

BUY
$36.45 - $46.68 $17,714 - $22,686
486 Added 0.45%
107,685 $5.03 Million
Q1 2023

May 15, 2023

BUY
$39.51 - $61.95 $52,627 - $82,517
1,332 Added 1.26%
107,199 $4.78 Million
Q4 2022

Feb 14, 2023

BUY
$38.6 - $62.07 $2.5 Million - $4.01 Million
64,680 Added 157.04%
105,867 $6.16 Million
Q3 2022

Nov 14, 2022

BUY
$42.86 - $77.02 $35,145 - $63,156
820 Added 2.03%
41,187 $1.77 Million
Q2 2022

Aug 15, 2022

BUY
$64.69 - $85.07 $776,926 - $1.02 Million
12,010 Added 42.35%
40,367 $2.91 Million
Q1 2022

May 13, 2022

BUY
$76.3 - $103.81 $2.16 Million - $2.94 Million
28,357 New
28,357 $2.35 Million
Q3 2020

Nov 13, 2020

SELL
$42.77 - $56.69 $929,862 - $1.23 Million
-21,741 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$26.54 - $44.24 $577,006 - $961,821
21,741 New
21,741 $961,000

Others Institutions Holding AZTA

About Azenta, Inc.


  • Ticker AZTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 75,020,400
  • Market Cap $3.56B
  • Description
  • Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sampl...
More about AZTA
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.